QUOTE(karmelaina @ 2016 12 22, 16:40)
Ačiū, bet ten ko gero reik skambinti, nes tarp atliekamų tyrimų nerandu kažko panašaus į NIPT'ą...
yra tas tyrimas CLARIGO NIPT , tik aprasymas yra anglu ir latviu kalba, rusiskai nera. nukopijuojau tau cia angliska aprasyma. Su nuolaida 240 euru tyrimas iki 2016 metu galo. Jiems galima rasyti emaila, kaip suorantu ir rusiskai galima rasyti ir pasiklausti.
Tests
Clarigo NIPT in E. Gulbis Laboratory ∧
Since May 1st, 2016 NIPT is being performed at E. Gulbis Laboratory.
Non-invasive screening of the most often trisomies with high precision.
The NIPT allows to analyze fetal DNA which circulates in maternal bloodstream in order to detect the most often (13., 18., and 21st chromosome) trisomies for the fetus as early as from the 10th week of pregnancy. Clarigo test has extremely high sensistivities and sensitivities and much lower false positive rate compared to the widely used serum screening tests which gives an extra confidence and allows to avoid unneccessary invasive (amniocentesis and /or Chorionic Villus Sampling). The NIPT allows to provide all pregnant women (both high and low risk) a fast, relieable and precise screening method.
Low amount of fetal DNA can be detected in the maternal bloodstream which allows to detect chromosomal aneploidies of chromosomes 13, 18 and 21 as well as the gender of the fetus (optional).
In order to perform the test it is possible to send already sampled material (at your doctors office) or patient can get sampled at any of E. Gulbis Laboratory sampling points.
Practical information:
Price: EUR 480,- (-50% discount until the end of the year 2016 for all high-risk pregnancies)
Results available after ~1 week
The test can be performed starting from week 10
Testing material maternal blood in Streck tube
Sampling can be done Monday-Thursday
ONLY singleton pregancies
Possible results
NEGATIVE T21, T18 and T13
POSITIVE (any of the trisomies)
Low Fetal Fraction (below 4%)
No results (DNA amplification not effective - extremely rare)
POSITIVE RESULT HAS TO BE CONFIRMED BY AN INVASIVE PROCEDURE
Specification (based on clinical study with more than 1900 samples):
· T21: sensitivity 100%, specificity 99,94%
· T18: sensitivity 95,00%, specificity 100%
· T13: sensitivity 100%, specificity 99,88%
Test should be not performed if abnormalities are detected during ultrasound.
* The high-risk pregnancy discount is available with doctors prescription and confirmation of high-risk.
Additional info:
Mikus Gavars
Molecular biologist
E. Gulbis Laboratory
e-mail: mikus.gavars@egl.lv
burbuliavo visas pilvas ir tuo pat jutau kazkokius prisilietimus 
Dabar gine israse gert nesciuju vitaminus.Kazkaip nesinori pumpuot ju.Juolab apetitu nesiskundziu.O jusu dsug kas juos geria?
